Jurgen Kuball Profile
Jurgen Kuball

@JKuball

Followers
351
Following
418
Statuses
372

https://t.co/uF2fJCMz0Q https://t.co/zsGsEWJgza

Utrecht, The Netherlands
Joined June 2015
Don't wanna be here? Send us removal request.
@JKuball
Jurgen Kuball
14 days
It’s always about creating and using better alternatives ….. now also on …..
0
0
0
@JKuball
Jurgen Kuball
2 months
0
4
0
@JKuball
Jurgen Kuball
2 months
Excellent presentation of ⁦@CChabannon⁩ on tisagenlecleucel for the Management of Patients with R/R DLBCL: an Interim Report of the European PASS Conducted by EBMT ⁦@TheEBMT_CTIWP⁩ ⁦@AnnalisaRugger1
Tweet media one
1
4
8
@JKuball
Jurgen Kuball
2 months
@gvhd_hub
GvHD Hub
2 months
CONGRESS #ASH24 | POSTER @Jkuball, @UMCUtrecht, presented a poster on MSCs in SR-aGvHD. ORR at day 7 was 26.5% and 44.5% at day 28. At 12 mo, NRM was 58.8%. 84.8% of day 7 responders maintained response to day 28. Follow our live feed for more updates: #GvHD #GvHDsm
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
2
4
@JKuball
Jurgen Kuball
2 months
RT @gvhd_hub: CONGRESS #ASH24 | POSTER @Jkuball, @UMCUtrecht, presented a poster on MSCs in SR-aGvHD. ORR at day 7 was 26.5% and 44.5% a…
0
2
0
@JKuball
Jurgen Kuball
2 months
RT @CChabannon: The @GoCARTcoalition is an inclusive initiative bringing together many stakeholders interested in the development of IECs b…
0
4
0
@JKuball
Jurgen Kuball
3 months
RT @TheEBMT: 🔎 Have you seen this publication in @BMTjournal? 📰 Severe ICANS after CAR T-cell therapy and assessment of prevention with le…
0
4
0
@JKuball
Jurgen Kuball
4 months
RT @LabMinguet: Do you know how to design innovative CAR T cells? The TCR is an incredible inspiration and has tons to teach us! Check our…
0
7
0
@JKuball
Jurgen Kuball
4 months
RT @AleParigiani: Excellent review from the lab about CAR design 😍 Look inside 👀
0
2
0
@JKuball
Jurgen Kuball
4 months
Amazing session at ⁦@_CTGCT_⁩ with ⁦Jane Kinghorn UCL and Heiko van der Leyen in Ljubljana on how to make translational medicine in ATMP development more efficient and attractive to a next generation of researchers, regulators and investors.
Tweet media one
Tweet media two
Tweet media three
0
3
13
@JKuball
Jurgen Kuball
4 months
RT @TheEBMT: The 1st Joint Educational Meeting of the Autoimmune Diseases & @TheEBMT_CTIWP Working Parties in Milan was a success! 👏 The ev…
0
5
0
@JKuball
Jurgen Kuball
4 months
RT @TheEBMT_CTIWP: Joined meeting in Milano CART in auto immune diseases and finally a joined picture of our amazing team 😀 ⁦@AnnalisaRugge
0
4
0
@JKuball
Jurgen Kuball
4 months
RT @TheEBMT: ��️ Live from 📍 Milan: We have just opened the joint meeting of Immunology and Cellular Therapies in Autoimmune Diseases! 💡 Du…
0
9
0
@JKuball
Jurgen Kuball
5 months
0
0
2
@JKuball
Jurgen Kuball
5 months
RT @BSilva_Santos: Excellent time in Utrecht giving seminar and talking science with @JKuball and @ZsoltSebestyen2 and colleagues :) https:…
0
1
0
@JKuball
Jurgen Kuball
6 months
After Movie ….. official opening of ICAT @cancercenterumc @CTI_UMCUtrecht @ZsoltSebestyen
0
0
0
@JKuball
Jurgen Kuball
7 months
Last days of a survey of ⁦@GoCARTcoalition⁩ ⁦@t2evolve_imi⁩ ⁦@TheEBMT_CTIWP⁩ on the needs for ATMP development. Which system or sensors we need, viral or non viral? One participant per hospital / company needed.
0
2
2
@JKuball
Jurgen Kuball
7 months
RT @CChabannon: Finally out The genesis of @TheEBMT #CART Cells registry @JKuball @Mohty_EBMT @AnnaSureda5 @Annalis
0
3
0
@JKuball
Jurgen Kuball
7 months
9000 it was and let’s go for the 10.000: Celebrating the registration of 9.000 patients treated with CAR T cell... @CChabannon @TheEBMT_CTIWP @AnnalisaRugger1 @AnnaSureda5 @TheEBMT @GoCARTcoalition
0
7
15
@JKuball
Jurgen Kuball
9 months
One day after world blood cancer day: stamina and world wide networks to advance are field are rewarded: Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort
0
1
3